Data Foundry

Drug recalls 2021

Morphine Sulfate Injection — Class II drug recall D-0856-2021

Terminated recall by Fresenius Kabi USA LLC, reported 2021-10-06, distributed nationwide. Defective container: Cracked vials leading to lack of sterility assurance

Recall numberD-0856-2021
Product typeDrug
ClassificationClass II
StatusTerminated
Voluntary or mandatedVoluntary
Recalling firmFresenius Kabi USA LLC, Melrose Park, IL, United States
Recall initiated2021-09-17
Classified2021-09-27
Reported by FDA2021-10-06
Terminated2023-06-20
DistributedNationwide (US)
Quantity963,000 vials
Reason classessterility, packaging
NDC63323-0451, 63323-0451-00, 63323-0451-01, 63323-0452, 63323-0452-00, 63323-0452-01, 63323-0454, 63323-0454-00, 63323-0454-01, 63323-0455, 63323-0455-00, 63323-0455-01, 63323-0458, 63323-0458-00, 63323-0458-01
Lot numbers6023731, 6023732, 6024172, 6024260
Expiration dates2023-03, 2023-06

Product

Morphine Sulfate Injection, USP, 2 mg per mL, 1 mL single dose vial, Rx only, Fresenius Kabi, Lake Zurich, IL 60047, NDC 63323-452-01. 25 vials per tray packaged 18 trays per shipper

Reason for recall

Defective container: Cracked vials leading to lack of sterility assurance

Machine access

This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-0856-2021. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.

Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.